Beyond Therapies
Tap into our comprehensive expertise across diverse therapy areas. We specialise in conducting research for both clinically complex and specialist indication areas, as well as general, primary care indications.
Our top therapy areas to work in are:
Navigate the complexities of oncology with strategic insight.
Oncology is fast-moving, competitive, and increasingly complex. There’s always something new - from novel modalities that bring fresh practical and logistical considerations, to evolving biomarkers that redefine how patients are selected and treated.
At the same time, as brands stretch across indications, messaging and positioning need to work in harmony across the full portfolio. All of this makes it essential to work with a partner who can see, and make sense of, the full landscape.
Stay ahead in the dynamic oncology landscape with deep scientific understanding, sharp awareness of market dynamics, technical fluency across stakeholder groups, and industry-leading moderation. This combination allows us to get to the heart of the challenge and deliver insights that drive confident decision-making.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Clear thinking for complex neurology challenges
Neurology is often defined by complex, progressive conditions where the goal is not cure, but slowing decline. This creates commercialisation challenges rooted in contradiction: the value of disease modification lies in early intervention, and yet at this stage symptoms may be subtle, intermittent or management appears straightforward.
The unmet need suggests that any slowing of decline should be meaningful, and yet when benefits are hard to see, building conviction among HCPs, families, and systems becomes a challenge.
At Beyond Blue, we understand the tension between evolving science and human behaviour. Complex journeys, human decisions, evolving science — these lie at the heart of commercialising neurology.
Explore how patients, caregivers, and clinicians perceive risk, progression, and value, and uncover what it takes to shift behaviour when benefits aren’t immediately visible, and how to build belief in disease-modifying therapies early, when they matter most.
See our latest thinking for more insights!
Connect the dots across Cardiorenalmetabolic (CVRM)
CVRM is undergoing a transformation. With rapid innovation across heart failure, diabetes, CKD, obesity, and beyond, the opportunity is growing - but so is the complexity.
It’s no longer a set of siloed indications, but an interconnected ecosystem with unique challenges: the breadth of the competitor landscape, increasingly dynamic patient segmentation, and shared care models that can blur lines of responsibility.
Get insights to connect the dots across therapeutic areas and specialties, decode real-world patient journeys, and track the shifting competitive landscape - so your strategy is always grounded in clarity, not guesswork.
See our latest thinking for more insights!
Excel in radiology research with unparallelled expertise
Radiology doesn’t sit neatly within traditional pharma. It’s a space where technology, diagnostics, and therapeutics converge - spanning med-tech devices, contrast agents, and fast-moving developments in software and AI.
But more than that, it’s a discipline built on workflows, efficiencies, and system-wide impact - not just clinical outcomes.
Leverage our extensive expertise across in the science, technology, and stakeholder landscape of radiology - so insights don’t just answer questions, they drive smarter decisions.
See our latest thinking for more insights!
Navigate the complexities of oncology with strategic insight.
Oncology is fast-moving, competitive, and increasingly complex. There’s always something new - from novel modalities that bring fresh practical and logistical considerations, to evolving biomarkers that redefine how patients are selected and treated.
At the same time, as brands stretch across indications, messaging and positioning need to work in harmony across the full portfolio. All of this makes it essential to work with a partner who can see, and make sense of, the full landscape.
Stay ahead in the dynamic oncology landscape with deep scientific understanding, sharp awareness of market dynamics, technical fluency across stakeholder groups, and industry-leading moderation. This combination allows us to get to the heart of the challenge and deliver insights that drive confident decision-making.
Check out our deep dive case study click below.
Oncology Trends, Views and Perspectives from Beyond Blue
What are the leading oncology issues and drug development trends, outside of reimbursement/drug access? What is the impact of COVID–19 across oncology? How can we use market research methods to maximise stakeholder insights on future oncology drug development,...
Clear thinking for complex neurology challenges
Neurology is often defined by complex, progressive conditions where the goal is not cure, but slowing decline. This creates commercialisation challenges rooted in contradiction: the value of disease modification lies in early intervention, and yet at this stage symptoms may be subtle, intermittent or management appears straightforward.
The unmet need suggests that any slowing of decline should be meaningful, and yet when benefits are hard to see, building conviction among HCPs, families, and systems becomes a challenge.
At Beyond Blue, we understand the tension between evolving science and human behaviour. Complex journeys, human decisions, evolving science — these lie at the heart of commercialising neurology.
Explore how patients, caregivers, and clinicians perceive risk, progression, and value, and uncover what it takes to shift behaviour when benefits aren’t immediately visible, and how to build belief in disease-modifying therapies early, when they matter most.
See our latest thinking for more insights!
Connect the dots across Cardiorenalmetabolic (CVRM)
CVRM is undergoing a transformation. With rapid innovation across heart failure, diabetes, CKD, obesity, and beyond, the opportunity is growing - but so is the complexity.
It’s no longer a set of siloed indications, but an interconnected ecosystem with unique challenges: the breadth of the competitor landscape, increasingly dynamic patient segmentation, and shared care models that can blur lines of responsibility.
Get insights to connect the dots across therapeutic areas and specialties, decode real-world patient journeys, and track the shifting competitive landscape - so your strategy is always grounded in clarity, not guesswork.
See our latest thinking for more insights!
Excel in radiology research with unparallelled expertise
Radiology doesn’t sit neatly within traditional pharma. It’s a space where technology, diagnostics, and therapeutics converge - spanning med-tech devices, contrast agents, and fast-moving developments in software and AI.
But more than that, it’s a discipline built on workflows, efficiencies, and system-wide impact - not just clinical outcomes.
Leverage our extensive expertise across in the science, technology, and stakeholder landscape of radiology - so insights don’t just answer questions, they drive smarter decisions.